These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 27419812)

  • 1. Antiretroviral Therapy Initiation Is Not Associated With Risky Sexual Behavior Among Heterosexual Human Immunodeficiency Virus-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Ngure K; Thomas KK; Katabira E; Baeten JM;
    Sex Transm Dis; 2017 Jan; 44(1):57-61. PubMed ID: 27898566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral Modeling and its Association with PrEP and ART Use in Ugandan HIV-Serodifferent Couples.
    Wang L; Muwonge TR; Simoni JM; Nambi F; Nakabugo L; Kibuuka J; Thomas D; Katz IT; Feutz E; Thomas KK; Ware NC; Wyatt MA; Kadama H; Mujugira A; Heffron R;
    AIDS Behav; 2024 May; 28(5):1719-1730. PubMed ID: 38361169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of Oral PrEP Adherence Among Young Kenyan Women: Implications for Promoting Effective PrEP Use.
    Musinguzi N; Pyra M; Bukusi EA; Mugo NR; Baeten JM; Haberer JE;
    AIDS Behav; 2023 Jan; 27(1):171-181. PubMed ID: 35841463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Risk Assessment Tool for Identifying Pregnant and Postpartum Women Who May Benefit From Preexposure Prophylaxis.
    Pintye J; Drake AL; Kinuthia J; Unger JA; Matemo D; Heffron RA; Barnabas RV; Kohler P; McClelland RS; John-Stewart G
    Clin Infect Dis; 2017 Mar; 64(6):751-758. PubMed ID: 28034882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderating Effect of Pre-Exposure Prophylaxis Use on the Association Between Sexual Risk Behavior and Perceived Risk of HIV Among Brazilian Gay, Bisexual, and Other Men Who Have Sex With Men: Cross-Sectional Study.
    Blair KJ; Torres TS; Hoagland B; Bezerra DRB; Veloso VG; Grinsztejn B; Clark J; Luz PM
    JMIR Public Health Surveill; 2023 Oct; 9():e45134. PubMed ID: 37796573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-serodifferent couples' perspectives and practices regarding HIV prevention strategies: A mixed methods study.
    McMahon JM; Simmons J; Braksmajer A; LeBlanc N
    PLOS Glob Public Health; 2022; 2(8):e0000620. PubMed ID: 36962775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya.
    Haberer JE; Mugo N; Bukusi EA; Ngure K; Kiptinness C; Oware K; Garrison LE; Musinguzi N; Pyra M; Valenzuela S; Thomas KK; Anderson PL; Thirumurthy H; Baeten JM
    J Acquir Immune Defic Syndr; 2022 Mar; 89(3):251-260. PubMed ID: 35147580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived risk versus objectively measured risk of HIV acquisition: a cross-sectional study among HIV-negative individuals in Serodiscordant partnerships with clients attending an Urban Clinic in Uganda.
    Tugume L; Muwonge TR; Joloba EN; Isunju JB; Kiweewa FM
    BMC Public Health; 2019 Nov; 19(1):1591. PubMed ID: 31783826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the European Portuguese version of the Perceived Risk of HIV Scale in the general population and HIV-uninfected partners from sero-different couples.
    Martins A; Chaves C; Canavarro MC; Pereira M
    BMC Public Health; 2019 Oct; 19(1):1336. PubMed ID: 31640612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy.
    Pintye J; Beima-Sofie KM; Makabong'O PA; Njoroge A; Trinidad SB; Heffron RA; Baeten JM; Celum C; Matemo D; Kinuthia J; Kelley MC; John-Stewart GC
    AIDS Patient Care STDS; 2018 Dec; 32(12):538-544. PubMed ID: 30036072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships.
    Pyra M; Brown ER; Haberer JE; Heffron R; Celum C; Bukusi EA; Asiimwe S; Katabira E; Mugo NR; Baeten JM;
    AIDS Behav; 2018 Nov; 22(11):3718-3725. PubMed ID: 30006791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya.
    Carroll JJ; Ngure K; Heffron R; Curran K; Mugo NR; Baeten JM
    AIDS Care; 2016 Aug; 28(8):1000-6. PubMed ID: 26754017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female and younger subjects have lower adherence in PrEP trials: a meta-analysis with implications for the uptake of PrEP service to prevent HIV.
    Yun K; Xu JJ; Zhang J; Li JM; Hu QH; Chu ZX; Jiang YJ; Geng WQ; Shang H; Wang N
    Sex Transm Infect; 2018 May; 94(3):163-168. PubMed ID: 28756409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
    Özdener AE; Park TE; Kalabalik J; Gupta R
    Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis.
    Carroll JJ; Heffron R; Mugo N; Ngure K; Ndase P; Asiimwe S; Celum C; Baeten JM
    Sex Transm Dis; 2016 Aug; 43(8):471-5. PubMed ID: 27419812
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.